In addition, the concentration of OGP in biopsies of responders was significantly higher than that in non‐responders before receiving neoadjuvant chemotherapy (Figure 8G), suggesting that OGP is associated with improved chemotherapy response in breast cancer patients. This evidence concerns the gene OVGP1 and breast carcinoma.